Wake me up before you go: A strategy to reduce the latent HIV reservoir

Nicolas Chomont, Afam Okoye, David Favre, Lydie Trautmann

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

: In the quest to eliminate or reduce the HIV reservoir, shock and kill strategies require the combined administration of a latency reversing agent (LRA) to reactivate the latent reservoir and an intervention to boost effector functions to clear this reservoir. Both parts of this strategy are quite inefficient when LRAs are administered to HIV-infected individuals on suppressive ART for several years, possibly due to low levels of induced antigen expression, negative impact of LRAs on clearance mechanisms, and very low number of effective cytotoxic T cells (CTLs). Here we provide rationale for an approach that would require only the administration of an LRA at the time of ART initiation to significantly reduce the HIV reservoir. The advantage of this strategy is an efficient reactivation of the latent HIV reservoir when high numbers of HIV-specific CD8+ T cells are present. This strategy may also potentiate more effective CTL responses and the establishment of a longer period of immune surveillance. This “window of opportunity” has been validated in silico, can be tested in preclinical non-human primate (NHP) models and translated rapidly in the clinic.

Original languageEnglish (US)
JournalAIDS
DOIs
StateAccepted/In press - Nov 10 2017

Fingerprint

HIV
T-Lymphocytes
Computer Simulation
Primates
Shock
Antigens

Keywords

  • CTL
  • HIV cure
  • latency reversing agent
  • latent reservoir
  • shock and kill

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Wake me up before you go : A strategy to reduce the latent HIV reservoir. / Chomont, Nicolas; Okoye, Afam; Favre, David; Trautmann, Lydie.

In: AIDS, 10.11.2017.

Research output: Contribution to journalArticle

Chomont, Nicolas ; Okoye, Afam ; Favre, David ; Trautmann, Lydie. / Wake me up before you go : A strategy to reduce the latent HIV reservoir. In: AIDS. 2017.
@article{cb13f1829ba9487a92e8558283f4b613,
title = "Wake me up before you go: A strategy to reduce the latent HIV reservoir",
abstract = ": In the quest to eliminate or reduce the HIV reservoir, shock and kill strategies require the combined administration of a latency reversing agent (LRA) to reactivate the latent reservoir and an intervention to boost effector functions to clear this reservoir. Both parts of this strategy are quite inefficient when LRAs are administered to HIV-infected individuals on suppressive ART for several years, possibly due to low levels of induced antigen expression, negative impact of LRAs on clearance mechanisms, and very low number of effective cytotoxic T cells (CTLs). Here we provide rationale for an approach that would require only the administration of an LRA at the time of ART initiation to significantly reduce the HIV reservoir. The advantage of this strategy is an efficient reactivation of the latent HIV reservoir when high numbers of HIV-specific CD8+ T cells are present. This strategy may also potentiate more effective CTL responses and the establishment of a longer period of immune surveillance. This “window of opportunity” has been validated in silico, can be tested in preclinical non-human primate (NHP) models and translated rapidly in the clinic.",
keywords = "CTL, HIV cure, latency reversing agent, latent reservoir, shock and kill",
author = "Nicolas Chomont and Afam Okoye and David Favre and Lydie Trautmann",
year = "2017",
month = "11",
day = "10",
doi = "10.1097/QAD.0000000000001695",
language = "English (US)",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Wake me up before you go

T2 - A strategy to reduce the latent HIV reservoir

AU - Chomont, Nicolas

AU - Okoye, Afam

AU - Favre, David

AU - Trautmann, Lydie

PY - 2017/11/10

Y1 - 2017/11/10

N2 - : In the quest to eliminate or reduce the HIV reservoir, shock and kill strategies require the combined administration of a latency reversing agent (LRA) to reactivate the latent reservoir and an intervention to boost effector functions to clear this reservoir. Both parts of this strategy are quite inefficient when LRAs are administered to HIV-infected individuals on suppressive ART for several years, possibly due to low levels of induced antigen expression, negative impact of LRAs on clearance mechanisms, and very low number of effective cytotoxic T cells (CTLs). Here we provide rationale for an approach that would require only the administration of an LRA at the time of ART initiation to significantly reduce the HIV reservoir. The advantage of this strategy is an efficient reactivation of the latent HIV reservoir when high numbers of HIV-specific CD8+ T cells are present. This strategy may also potentiate more effective CTL responses and the establishment of a longer period of immune surveillance. This “window of opportunity” has been validated in silico, can be tested in preclinical non-human primate (NHP) models and translated rapidly in the clinic.

AB - : In the quest to eliminate or reduce the HIV reservoir, shock and kill strategies require the combined administration of a latency reversing agent (LRA) to reactivate the latent reservoir and an intervention to boost effector functions to clear this reservoir. Both parts of this strategy are quite inefficient when LRAs are administered to HIV-infected individuals on suppressive ART for several years, possibly due to low levels of induced antigen expression, negative impact of LRAs on clearance mechanisms, and very low number of effective cytotoxic T cells (CTLs). Here we provide rationale for an approach that would require only the administration of an LRA at the time of ART initiation to significantly reduce the HIV reservoir. The advantage of this strategy is an efficient reactivation of the latent HIV reservoir when high numbers of HIV-specific CD8+ T cells are present. This strategy may also potentiate more effective CTL responses and the establishment of a longer period of immune surveillance. This “window of opportunity” has been validated in silico, can be tested in preclinical non-human primate (NHP) models and translated rapidly in the clinic.

KW - CTL

KW - HIV cure

KW - latency reversing agent

KW - latent reservoir

KW - shock and kill

UR - http://www.scopus.com/inward/record.url?scp=85033581921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033581921&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000001695

DO - 10.1097/QAD.0000000000001695

M3 - Article

C2 - 29135580

AN - SCOPUS:85033581921

JO - AIDS

JF - AIDS

SN - 0269-9370

ER -